Literature DB >> 22335856

Long-term (5- to 20-year) outcomes after transcatheter or surgical treatment of hemodynamically significant isolated secundum atrial septal defect.

Shelby Kutty1, Anas Abu Hazeem, Kimberly Brown, Christopher J Danford, Sarah E Worley, Jeffrey W Delaney, David A Danford, Larry A Latson.   

Abstract

Truly long-term follow-up data after transcatheter closure (TC) of atrial septal defects (ASDs) are scarce. We report the 5- to 20-year outcomes of TC and surgical closure (SC) for typical secundum ASD. We reviewed the records of patients with isolated secundum ASD and right ventricular volume overload who underwent TC or SC (January 1, 1986 to September 30, 2005). Follow-up was obtained through a combination of chart review, physician records, and telephone survey. We identified 375 patients (207 SC and 168 TC) and obtained follow-up data >5 years (median follow-up 10 years) for 300 (152 SC, 148 TC). Nine patients have died (3%). The New York Heart Association functional class was unchanged in 227 patients, improved in 25, and was worse in 15. Clinically significant arrhythmia was found in 28 patients (9.3%); 21% aged >40 years developed arrhythmia. On multivariate analysis, the odds of significant arrhythmia tended to be greater in the SC group, but this was statistically insignificant (95% confidence interval 0.68 to 3.9, p = 0.27). Age and preprocedure arrhythmia, but not TC or SC, were independent risk factors for late arrhythmia (p <0.001). No difference was found in the incidence of late, probably embolic, stroke in the TC (3%) versus SC (2%) groups. In conclusion, long-term outcomes after secundum ASD closure using modern methods are excellent. No significant differences were found between TC versus SC with regard to survival, functional capacity, atrial arrhythmias, or embolic neurologic events. Arrhythmia and neurologic events remain long-term risks after ASD closure, especially if the patient had pre-existing arrhythmia.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22335856     DOI: 10.1016/j.amjcard.2011.12.031

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  21 in total

1.  Impact of the Amplatzer atrial septal occluder device on left ventricular function in pediatric patients.

Authors:  Biagio Castaldi; Giuseppe Santoro; Giovanni Di Salvo; Gianpiero Gaio; Maria Teresa Palladino; Fabio D'Aiello; Carola Iacono; Giuseppe Pacileo; Raffaele Calabrò; Maria Giovanna Russo
Journal:  Pediatr Cardiol       Date:  2013-04-17       Impact factor: 1.655

2.  Post-pericardiotomy syndrome in pediatric patients following surgical closure of secundum atrial septal defects: incidence and risk factors.

Authors:  Howard J Heching; Emile A Bacha; Leonardo Liberman
Journal:  Pediatr Cardiol       Date:  2014-10-08       Impact factor: 1.655

Review 3.  State-of-the-Art Atrial Septal Defect Closure Devices for Congenital Heart.

Authors:  Michael L O'Byrne; Daniel S Levi
Journal:  Interv Cardiol Clin       Date:  2019-01

4.  Supraventricular Arrhythmias in Patients with Adult Congenital Heart Disease.

Authors:  Carina Blomström Lundqvist; Tatjana S Potpara; Helena Malmborg
Journal:  Arrhythm Electrophysiol Rev       Date:  2017-06

5.  Cost comparison of transcatheter and operative closures of ostium secundum atrial septal defects.

Authors:  Michael L O'Byrne; Matthew J Gillespie; Russell T Shinohara; Yoav Dori; Jonathan J Rome; Andrew C Glatz
Journal:  Am Heart J       Date:  2015-02-21       Impact factor: 4.749

6.  Transcatheter Closure of Atrial Septal Defects using the GORE(®) Septal Occluder in Children Less Than 10 kg of Body Weight.

Authors:  Tariq Abu-Tair; Christiane M Wiethoff; Jascha Kehr; Wlodzimierz Kuroczynski; Christoph Kampmann
Journal:  Pediatr Cardiol       Date:  2016-02-19       Impact factor: 1.655

7.  Increasing propensity to pursue operative closure of atrial septal defects following changes in the instructions for use of the Amplatzer Septal Occluder device: An observational study using data from the Pediatric Health Information Systems database.

Authors:  Michael L O'Byrne; Russell T Shinohara; Elena K Grant; Joshua P Kanter; Matthew J Gillespie; Yoav Dori; Jonathan J Rome; Andrew C Glatz
Journal:  Am Heart J       Date:  2017-07-19       Impact factor: 4.749

8.  Lower Hospital Charges and Societal Costs for Catheter Device Closure of Atrial Septal Defects.

Authors:  Jessica N Sanchez; Michael D Seckeler
Journal:  Pediatr Cardiol       Date:  2017-07-05       Impact factor: 1.655

9.  The influence of deficient retro-aortic rim on technical success and early adverse events following device closure of secundum atrial septal defects: An Analysis of the IMPACT Registry®.

Authors:  Michael L O'Byrne; Matthew J Gillespie; Kevin F Kennedy; Yoav Dori; Jonathan J Rome; Andrew C Glatz
Journal:  Catheter Cardiovasc Interv       Date:  2016-05-18       Impact factor: 2.692

Review 10.  Transcatheter device closure of atrial septal defects: more to think about than just closing the hole.

Authors:  Michael L O'Byrne; Andrew C Glatz; Matthew J Gillespie
Journal:  Curr Opin Cardiol       Date:  2018-01       Impact factor: 2.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.